Loading insider details...
Latest Form 4 (Oct 2, 2026): Exercise/Conversion of 4,384 MNPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 4,384 | n/a |
| Jul 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 5,254 | n/a |
| Apr 2, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 3,514 | n/a |
| Jan 5, 2026 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 4,326 | n/a |
| Dec 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 8,969 | n/a |
| Oct 2, 2025 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 4,327 | n/a |
| Jul 2, 2025 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 6,863 | n/a |
| Apr 3, 2025 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 1,791 | n/a |
| Mar 8, 2025 | Monopar Therapeutics (MNPR) | Grant/Award | 43,445 | n/a |
| Jan 2, 2025 | Monopar Therapeutics (MNPR) | Exercise/Conversion | 1,790 | n/a |